Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Cytotoxicity Assay From Fractions of Hedyotis corymbosa Extract Against Breast Cancer Cell Line T47D

Indonesian Journal of Cancer Chemoprevention · Vol. 2 No. 1 (2011) · hlm. 182–186

DOI
10.14499/indonesianjcanchemoprev2iss1pp182-186
ISSN
2355-8989, 2088-0197
Terbit
2011-02-28
Penerbit
Indonesian Society for Cancer Chemoprevention
Bahasa
eng

Abstrak

Drug discovery for cancer medication is the most important effort that researcher do at this time. Indonesia bio diversities have possibility as a cancer medicine sources. Finding a herbal medicine for cancer treatment is a first step to find a right cancer medicine in the future. This research has already completed for the earlier another research. Some fractions of Hedyotis corymbosa extract has been analyzed using Sulforhodamine B method with UV wavelength 515 nm against T47D cell line, a human breast cancer. There are Hexane extract, Methylene chloride extract and Ethyl acetate extract, and give inhibitory concentration 50 (IC50) of 33.45 µg/ml, 54.59 µg/ml and 52.58 µg/ml, respectively. Ethanolic extract, itself has IC50 of 61.57 µg/ml, whereas IC50 value of Cisplatinum is 9.63 µg/ml. There is a difference between the ethanolic extracts with the other fraction.Keywords: breast cancer, herbal medicine, T47D, Hedyotis corymbosa

Jaringan kolaborasi para penulis

23 penulis · 72 tautan kepenulisan bersama · 43 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Indonesian Institute of Sciences
  • Maranatha Christian University
  • Universitas Gadjah Mada
  • Osaka City University
  • Universitas Muhammadiyah Sukabumi
  • Universitas Trisakti
  • National Research and Innovation Agency
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Sri HandayaniIndonesian Institute of Sciences3
Edy MeiyantoUniversitas Gadjah Mada2
Ratna Asmah SusidartiUniversitas Gadjah Mada2
Riris Istighfari JenieUniversitas Gadjah Mada2
Wahyu WidowatiMaranatha Christian University2
Tjandrawati MozefIndonesian Institute of Sciences2
Teresa Liliana WargasetiaMaranatha Christian University1
Khie KhiongMaranatha Christian University1
Ferry SandraUniversitas Trisakti1
Hana RatnawatiMaranatha Christian University1
Susi TjahyaniMaranatha Christian University1
Puspa Dewi LotulungIndonesian Institute of Sciences1
Nina ArtantiIndonesian Institute of Sciences1
Linar Zalinar UdinIndonesian Institute of Sciences1
Muhammad HanafiNational Research and Innovation Agency1
Vienna SaraswatyIndonesian Institute of Sciences1
Ken Ichi FujitaOsaka City University1
Yoshinosuke UsukiOsaka City University1
Lela mukmilahUniversitas Muhammadiyah Sukabumi1
Elis LisnawatiUniversitas Muhammadiyah Sukabumi1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ijcc.chemoprev.org/index.php/ijcc/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Cytotoxicity Assay From Fractions of Hedyotis corymbosa Extract Against Breast Cancer Cell Line T47D</dc:title>
	<dc:creator>Andriyani, Rina</dc:creator>
	<dc:creator>Risdian, Chandra</dc:creator>
	<dc:creator>Udin, Zalinar</dc:creator>
	<dc:description xml:lang="en-US">Drug discovery for cancer medication is the most important effort that researcher do at this time. Indonesia bio diversities have possibility as a cancer medicine sources. Finding a herbal medicine for cancer treatment is a first step to find a right cancer medicine in the future. This research has already completed for the earlier another research. Some fractions of Hedyotis corymbosa extract has been analyzed using Sulforhodamine B method with UV wavelength 515 nm against T47D cell line, a human breast cancer. There are Hexane extract, Methylene chloride extract and Ethyl acetate extract, and give inhibitory concentration 50 (IC50)  of 33.45 µg/ml, 54.59 µg/ml and 52.58 µg/ml, respectively. Ethanolic extract, itself has IC50 of 61.57 µg/ml, whereas IC50 value of Cisplatinum is  9.63 µg/ml. There is a difference between the ethanolic extracts with the other fraction.Keywords: breast cancer, herbal medicine, T47D, Hedyotis corymbosa</dc:description>
	<dc:publisher xml:lang="en-US">Indonesian Society for Cancer Chemoprevention</dc:publisher>
	<dc:contributor xml:lang="en-US"></dc:contributor>
	<dc:date>2011-02-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ijcc.chemoprev.org/index.php/ijcc/article/view/29</dc:identifier>
	<dc:identifier>10.14499/indonesianjcanchemoprev2iss1pp182-186</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Cancer Chemoprevention; Vol 2, No 1 (2011); 182-186</dc:source>
	<dc:source>2355-8989</dc:source>
	<dc:source>2088-0197</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ijcc.chemoprev.org/index.php/ijcc/article/view/29/30</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Indonesian Journal of Cancer Chemoprevention</dc:rights>
</oai_dc:dc>